DEFLAT 40mg/ml Price

Overview

Welcome to Dwaey, specifically on DEFLAT 40mg/ml Drops (Oral) page.
This medicine contains an important and useful components, as it consists of Simethicone.
DEFLAT 40mg/ml is available in the market in concentration 40mg/ml and in the form of Drops (Oral).

HAYAT PHARMACEUTICAL INDUSTRIES CO. LTD. is the producer of DEFLAT 40mg/ml and it is imported from JORDAN, The most popular alternatives of DEFLAT 40mg/ml are listed downward .

Mode Of Action

Glucose is the end product of carbohydrate metabolism and is the chief source of energy for all cellular activities. Potassium chloride is a major cation of the intracellular fluid. It plays an active role in the conduction of nerve impulses in the heart, brain and skeletal muscle; contraction of cardiac skeletal and smooth muscles; maintenance of normal renal function, acid-base balance, carbohydrate metabolism and gastric secretion. Potassium citrate is absorbed and metabolized to potassium bicarbonate and this acts as a systemic alkalizer .

Indication

• Diarrhea
• Gastro-enteritis with dehydration

Precaution

Use water ONLY to mix Gastrolyte Electrolyte Rehydration Formula powder or effervescent tablets. Never dilute with lemonade, soft drinks, cordials or any other fluid than water. Gastrolyte Electrolyte Rehydration Formula powder is available with either sodium saccharin or aspartame as a sweetening agent. Phenylketonurics are warned that this product, in some forms, contains phenylalanine. Please refer to the packaging for information relating to the sweetening agent used. For oral administration only. The contents of one sachet or two effervescent tablets should always be made up to 200ml with water (the product must not be reconstituted in diluents other than water, e.g. must not be included in milk solutions). A weaker solution than recommended will fail to provide adequate sugar and electrolytes and a stronger solution than recommended may give rise to hypernatraemia. Intravenous rehydration is required for dehydrated children with shock, very large stool losses (>10mL/kg/hour), severe vomiting that interferes with oral fluid replacement, or glucose malabsorption. Patients with gastroenteritis should be monitored carefully to ensure that their condition does not deteriorate. In particular, young infants may become severely dehydrated in a short time. Patients and/or parents should be advised to seek medical advice if the condition worsens. Clinicians should particularly ensure patients are aware of the risk of dehydration in young children and infants. Early warning signs of impending dehydration should be discussed. Seek medical advice if diarrhoea persists for more than 6 hours in infants under 6 months, 12 hours in children aged 6 months to 3 years, 24 hours in children aged 3 to 6 years and 48 hours in children over 6 years of age.

Side Effects

• None reported.

Contra indication

There are no known contraindications to Gastrolyte Electrolyte Rehydration Formula. However, there may be a number of conditions where treatment with Gastrolyte Electrolyte Rehydration Formula will be inappropriate, e.g. intestinal obstruction requiring surgical intervention.

Pregnancy and lactation